Article: Severe intellectual disability and autistic features associated with microduplication 2q23.1

We thank the families for participating in the study, as well as The Centre for Applied Genomics (http://www.tcag.ca). We also thank A Fiebig, A Franke, and S Schreiber at POPGEN (University of Kiel, Kiel, Germany), A Stewart, R McPherson, and R Roberts of the University of Ottawa Heart Institute (University of Ottawa, Ottawa, Canada), the Wellcome Trust Case Control Consortium (WTCCC), the DECIPHER Consortium, and the Study of Addiction: Genetics and Environment (SAGE) consortium for generously providing population control microarray data. SWS is supported by The Centre for Applied Genomics (http://www.tcag.ca), Genome Canada and the Ontario Genomics Institute, the Canadian Institutes for Health Research (CIHR), the Canadian Institute for Advanced Research (CIFAR), the McLaughlin Centre, the Canada Foundation for Innovation, the Ontario Ministry of Research and Innovation and the Hospital for Sick Children Foundation. SWS holds the GlaxoSmithKline-CIHR Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children. This study was supported, in part, by the Fondation Jerome Lejeune (SHE).